PHASE3

A Multicenter, Open-label, Randomized, Study With Single-arm Extension Period to Assess the Pharmacokinetics, Safety and Efficacy of Macitentan Versus Standard of Care in Children With Pulmonary Arterial Hypertension — PHASE3

A Phase 3 multicenter, open-label, randomized study with single-arm extension period has been completed, assessing pharmacokinetics, safety, and efficacy of macitentan versus standard of care in children with pulmonary arterial hypertension. The trial evaluated the investigational therapy in the pediatric population with this rare cardiovascular condition.

9h ago·1 min read